Drug Landscape ›
benzoyl peroxide wash ›
Regulatory · United States
Marketing authorisation
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 20 April 2025 – 20 April 2026
Total reports: 23
Most-reported reactions
Erythema — 5 reports (21.74%) Drug Ineffective — 2 reports (8.7%) Dry Skin — 2 reports (8.7%) Heart Rate Increased — 2 reports (8.7%) Lip Dry — 2 reports (8.7%) Mental Disorder — 2 reports (8.7%) Off Label Use — 2 reports (8.7%) Rash — 2 reports (8.7%) Scar — 2 reports (8.7%) Skin Exfoliation — 2 reports (8.7%)
Source database →
benzoyl peroxide wash in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is benzoyl peroxide wash approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for benzoyl peroxide wash in United States?
Bausch Health Americas, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.